GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Progressive Care Inc (OTCPK:RXMD) » Definitions » EV-to-Revenue

RXMD (Progressive Care) EV-to-Revenue : 0.12 (As of Oct. 31, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Progressive Care EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Progressive Care's enterprise value is $6.47 Mil. Progressive Care's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was $54.88 Mil. Therefore, Progressive Care's EV-to-Revenue for today is 0.12.

The historical rank and industry rank for Progressive Care's EV-to-Revenue or its related term are showing as below:

RXMD' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.01   Med: 0.53   Max: 3.91
Current: 0.12

During the past 13 years, the highest EV-to-Revenue of Progressive Care was 3.91. The lowest was 0.01. And the median was 0.53.

RXMD's EV-to-Revenue is ranked better than
96.07% of 661 companies
in the Healthcare Providers & Services industry
Industry Median: 1.76 vs RXMD: 0.12

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-10-31), Progressive Care's stock price is $2.11. Progressive Care's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was $8.82. Therefore, Progressive Care's PS Ratio for today is 0.24.


Progressive Care EV-to-Revenue Historical Data

The historical data trend for Progressive Care's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Progressive Care EV-to-Revenue Chart

Progressive Care Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.80 0.49 0.46 0.44 -

Progressive Care Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.43 - 0.20 0.05

Competitive Comparison of Progressive Care's EV-to-Revenue

For the Pharmaceutical Retailers subindustry, Progressive Care's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Progressive Care's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Progressive Care's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Progressive Care's EV-to-Revenue falls into.



Progressive Care EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Progressive Care's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=6.468/54.884
=0.12

Progressive Care's current Enterprise Value is $6.47 Mil.
Progressive Care's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $54.88 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Progressive Care  (OTCPK:RXMD) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Progressive Care's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=2.11/8.824
=0.24

Progressive Care's share price for today is $2.11.
Progressive Care's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.82.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Progressive Care EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Progressive Care's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Progressive Care Business Description

Traded in Other Exchanges
N/A
Address
400 Ansin Boulevard, Suite A, Hallandale Beach, FL, USA, 33009
Progressive Care Inc is a personalized healthcare services and technology company that provides prescription pharmaceutical services, risk management, and data analytics to healthcare organizations and providers. The company through its wholly-owned subsidiary Pharmco, provides prescription pharmaceuticals, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, the supply of prescription medications to long-term care facilities, and health practice risk management. It also offers certain disease testing and vaccinations. It offers services in a variety of languages, including English, Spanish, French, Creole, Portuguese, Ukrainian, and Russian.
Executives
Charles M. Fernandez director, 10 percent owner, officer: Chairman & CEO C/O FAIRHOLME CAPITAL MANAGEMENT, L.L.C., 4400 BISCAYNE BOULEVARD, 9TH FLOOR, MIAMI FL 33137
Rodney Barreto director, 10 percent owner 460 MARQUESA DRIVE, CORAL GABLES FL 33156
Pamela M Roberts officer: CHIEF OPERATING OFFICER 1540 NW 203 ST, MIAMI FL 33169
Pedro Rodriguez director 258 NE 27TH STREET, MIAMI FL 33137
Birute Norkute officer: Chief Operating Officer 2311 NE 174TH ST, MIAMI FL 33160
Alan Jay Weisberg officer: CHIEF FINANCIAL OFFICER 2500 NORTH MILITARY TRAIL, SUITE 206, BOCA RATON FL 33431
Cecile Munnik officer: CFO 400 ANSIN BLVD SUITE A, HALLANDALE BEACH FL 33009
Joseph Ziegler director 1051 HILLSBORO MILE, PH2, HILLSBORO BEACH FL 33062
Jervis Hough director 6053 BARTAM COVE, DULUTH GA 30097
Shital P Parikh director, officer: Chief Operating Officer 1111 PARK CENTER BLVD., SUITE 202, MIAMI GARDENS FL 33169
Vernon Watson officer: Chief Executive Officer 1111 PARK CENTER BLVD., SUITE 202, MIAMI GARDENS FL 33169
Armen Karapetyan 10 percent owner 17395 NORTH BAY ROAD, SUITE 102, SUNNY ISLES BEACH FL 33160
Avraham A. Friedman director, 10 percent owner, officer: Chief Executive Officer C/O PROGRESSIVE CARE INC., 901 N. MIAMI BEACH BLVD., SUITE 1, N. MIAMI BEACH FL 33162
Andy Subachan director, 10 percent owner, officer: Chief Operating Officer C/O PROGRESSIVE CARE INC., 901 N. MIAMI BEACH BLVD., SUITE 1, N. MIAMI BEACH FL 33162
Buddy Young director, 10 percent owner, officer: President, CEO, CFO, Chairman